Cargando…
Novel DNA methylation biomarkers in stool and blood for early detection of colorectal cancer and precancerous lesions
BACKGROUND: Early detection and prevention of precancerous lesions can significantly reduce the morbidity and mortality of colorectal cancer (CRC). Here, we developed new candidate CpG site biomarkers for CRC and evaluated the diagnostic value of their expression in blood and stool samples of CRC an...
Autores principales: | Shen, Yuguang, Wang, Dongyang, Yuan, Tianli, Fang, Hongsheng, Zhu, Chen, Qin, Juan, Xu, Xiaojing, Zhang, Cheng, Liu, Jiahua, Zhang, Yuanruohan, Wen, Zhoujin, Tang, Jian, Wang, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938553/ https://www.ncbi.nlm.nih.gov/pubmed/36803423 http://dx.doi.org/10.1186/s13148-023-01443-7 |
Ejemplares similares
-
Precancerous Lesions in Colorectal Cancer
por: Sandouk, Fayez, et al.
Publicado: (2013) -
A novel screening method of DNA methylation biomarkers helps to improve the detection of colorectal cancer and precancerous lesions
por: Li, Yuan, et al.
Publicado: (2023) -
DNA methylation biomarkers in stool for early screening of colorectal cancer
por: Chen, Jie, et al.
Publicado: (2019) -
Epigenetic silencing of monoallelically methylated miRNA loci in precancerous colorectal lesions
por: Menigatti, M, et al.
Publicado: (2013) -
A New Method for the Detection of Colorectal Cancer and the Precancerous Lesions: Occult Blood Testing Combination with Promoter Methylation in the Fecal Sample
por: Wang, Dan-Yang, et al.
Publicado: (2021)